Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $157.4900 (-0.71%) ($154.1300 - $159.3200) on Fri. Apr. 27, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.04% (three month average) | RSI | 53 | Latest Price | $157.4900(-0.71%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -1.2% a day on average for past five trading days. | Weekly Trend | LGND declines -1.5% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(59%) IWO(57%) XBI(56%) IWC(53%) IWM(53%) | Factors Impacting LGND price | LGND will decline at least -1.02% in a week (0% probabilities). TLT(-15%) VIXM(-13%) UUP(-8%) GDXJ(-6%) DIA(-5%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.02% (StdDev 2.04%) | Hourly BBV | 0 () | Intraday Trend | -1.1% | | | |
|
Resistance Level | $162.85 | 5 Day Moving Average | $159.96(-1.54%) | 10 Day Moving Average | $164.13(-4.05%) | 20 Day Moving Average | $162.85(-3.29%) | To recent high | -13.8% | To recent low | 5% | Market Cap | $2.531b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |